Bone cement assessed in screw trial:
This article was originally published in Clinica
Orthopaedics biomaterials company Orthovita is to begin a Norwegian clinical trial of its bone bonding cement for augmenting screws used in fracture-repairing plate constructs where the screws have failed to hold due to poor bone quality. Orthocomp, which will be assessed in the treatment of long-bone fractures, sets within minutes and becomes immediately load-bearing. The non-resorbable cement could act as an internal nut to the screw and allow the screw to stabilise the fracture, said the Malvern, Pennsylvania-based company.
You may also be interested in...
US FDA usually recommends using overall survival for pancreatic cancer drugs, but AstraZeneca choose progression-free survival; now ODAC will weigh in on whether the PARP inhibitor olaparib demonstrated a clinically meaningful impact. The firm cites enrollment and design challenges in the gBRCAm population as reasons for using PFS.
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.